Email this page
Print
Bookmark and share
Bigger
Smaller
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
New York Heart Association grading of heart failure (NYHA)New York Heart Association grading of heart failure (NYHA)
Published 2008-12-01 00:00:00
This page contains additional content about the article Rosiglitazone (Avandia) and rosiglitazone with metformin (Avandamet) for type 2 diabetes mellitus, first published in NPS RADAR in April 2004, and last updated in December 2008.
New York Heart Association grading of heart failure (NYHA)
Class I
No limitations. Ordinary physical activity does not cause undue fatigue, dyspnoea or palpitations (asymptomatic left ventricular dysfunction).
Class II
Slight limitation of physical activity. Ordinary physical activity results in fatigue, palpitation, dyspnoea or angina pectoris (mild chronic heart failure).
Class III
Marked limitation of physical activity. Less than ordinary physical activity leads to symptoms (moderate chronic heart failure).
Class IV
Unable to carry on any physical activity without discomfort. Symptoms of chronic heart failure present at rest (severe chronic heart failure).
Date published: 2008-12-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
